W Konrad Karcz,William von Braun
W Konrad Karcz
Background: Reduction in operative trauma along with an improvement in endoscopic access has undoubtedly occupied surgical minds for at least the past 3 decades. It is not at all surprising that minimally invasive colon s...
Surgery for Colorectal Cancer - Trends, Developments, and Future Perspectives [0.03%]
结直肠癌外科治疗：趋势、进展和未来前景
Markus Rentsch,Tobias Schiergens,Andrej Khandoga et al.
Markus Rentsch et al.
Background: Although colorectal surgery is long established as the mainstay treatment for colon cancer, certain topics regarding technical fine-tuning to increase postsurgical recurrence-free survival have remained a matt...
Treatment of Metastatic Colorectal Cancer: Standard of Care and Future Perspectives [0.03%]
转移性结直肠癌的治疗：常规疗法与未来展望
Julian Holch,Sebastian Stintzing,Volker Heinemann
Julian Holch
Palliative chemotherapy for metastatic colorectal cancer has undergone substantial changes in recent years. The implementation of modern biologicals in the treatment has substantially improved overall survival up to 30 months. With the incr...
Radiotherapy for Colorectal Cancer: Current Standards and Future Perspectives [0.03%]
结直肠癌放疗：现状与未来展望
Matthias F Häfner,Jürgen Debus
Matthias F Häfner
Background: Multimodal treatment approaches are indispensable for patients with advanced-stage colorectal cancer. Radiotherapy has been established as essential part of perioperative concepts and was introduced as an opti...
Bettina Baeßler,David Maintz,Thorsten Persigehl
Bettina Baeßler
Background: Radiological imaging plays an important role in the setting of staging, follow-up, and imaging-guided treatment of colorectal carcinoma (CRC). ...
Frank T Kolligs
Frank T Kolligs
Colorectal cancer is one of the leading causes of cancer-related morbidity and mortality. Main risk factors include advanced age, family history, male sex, and lifestyle factors. Screening can reduce incidence and death from colorectal canc...
Jens Werner,Volker Heinemann
Jens Werner
Incidence of Metachronous Distant Metastasis and ypN Classification Influence Patient Survival in Endosonographically Confirmed uT3 Rectal Cancer after Neoadjuvant Therapy and R0 Resection: A Historical Cohort Analysis [0.03%]
内镜超声确诊的uT3期直肠癌新辅助治疗和R0切除后继发远处转移的发生及 ypN分期影响患者预后：历史性队列研究分析
Achim Troja,Hans-Günther Hempen,Mareike Demmer et al.
Achim Troja et al.
Background: Tumor response after neoadjuvant radiochemotherapy (NRC) prior to surgery and other parameters are likely to have an influence on the survival rate of patients suffering from T3 rectal cancer. ...
Antiviral Therapy in Patients with Viral Hepatitis and Hepatocellular Carcinoma: Indications and Prognosis [0.03%]
病毒性肝炎和 hepatocellular carcinoma患者中的抗病毒治疗：适应证及预后
Christoph Roderburg,Frank Tacke,Christian Trautwein
Christoph Roderburg
Background: Chronic hepatitis B and C infections represent major risk factors for the development of hepatocellular carcinoma (HCC). Recently, the management of patients with viral hepatitis has dramatically changed. In t...
Diagnostics and Treatment of Hepatocellular Carcinoma in 2016: Standards and Developments [0.03%]
2016年肝细胞癌的诊断和治疗：规范与进展
Jörg Trojan,Stephan Zangos,Andreas A Schnitzbauer
Jörg Trojan
Background: Hepatocellular carcinoma (HCC) is a frequent complication of liver cirrhosis. Worldwide, HCC is one of the most common cancers, with a rising incidence. ...